Paracetamol therapy for patent ductus arteriosus in premature i̇nfants: A chance before surgical ligation

Pediatric Cardiology

Volumn 35, Issue 2, 2014, Pages 276-279

  Özdemir, Özmert M A ^a   Doǧan, Mustafa ^a   Küçüktaşçi, Kazim ^a   Ergin, Hacer ^a   Şahin, Özlem ^a  

^a PAMUKKALE UNIVERSITY   (Turkey)

Author keywords

Ibuprofen; Paracetamol; Patent ductus arteriosus; Premature

Indexed keywords

PARACETAMOL;

ABSENCE OF SIDE EFFECTS; ARTICLE; BIRTH WEIGHT; CLINICAL ARTICLE; FOLLOW UP; GESTATIONAL AGE; HUMAN; NEWBORN; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PREOPERATIVE TREATMENT; TREATMENT OUTCOME;

ACETAMINOPHEN; ADMINISTRATION, ORAL; ANALGESICS, NON-NARCOTIC; CARDIAC SURGICAL PROCEDURES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DUCTUS ARTERIOSUS, PATENT; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; LIGATION; MALE; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84893713034     PISSN: 01720643     EISSN: 14321971     Source Type: Journal    
DOI: 10.1007/s00246-013-0770-9     Document Type: Article

References (13)

1. Chiruvolu A, Jaleel MA (2009) Therapeutic management of patent ductus arteriosus. Early Hum Dev 85:151-155
2. Clyman RI (2012) Patent ductus arteriosus in the preterm infant. In: Gleason CA, Devaskar SU (eds) Avery's diseases of the newborn, 9th edn. Elsevier Saunders, Philadelphia, pp 751-761
3. Gokmen T, Erdeve O, Altug N, Oguz SS, Uras N, Dilmen U (2011) Efficacy and safety of oral versus intravenous ibuprofen in very-low-birthweight preterm infants with patent ductus arteriosus. J Pediatr 158:549-554
4. Hammerman C, Bin-Nun A, Markovitch E, Schimmel MS, Kaplan M, Fink D (2011) Ductal closure with paracetamol: a surprising new approach to patent ductus arteriosus treatment. Pediatrics 128:1618-1621
5. Hamrick SE, Hansmann G (2010) Patent ductus arteriosus of the preterm infant. Pediatrics 125:1020-1030
6. Kulmacz RJ, Wang LH (1995) Comparison of hydroperoxide initiator requirements for the cyclooxygenase activities of prostaglandin H synthase-1 and -2. J Biol Chem 270:24019-24023
7. Lucas R, Warner TD, Vojnovic I, Mitchell JA (2005) Cellular mechanisms of acetaminophen: role of cyclo-oxygenase. FASEB J 19:635-637
8. Oncel MY, Yurttutan S, Uras N, Altug N, Ozdemir R, Ekmen S et al (2013) An alternative drug (paracetamol) in the management of patent ductus arteriosus in ibuprofen-resistant or contraindicated preterm infants. Arch Dis Child Fetal Neonatal Ed 98:F94
9. Oncel MY, Yurttutan S, Degirmencioglu H, Uras N, Altug N, Erdeve O et al (2013) Intravenous paracetamol treatment in the management of patent ductus arteriosus in extremely low birth weight infants. Neonatology 103:166-169
10. Tekgunduz KS, Ceviz N, Demirelli Y, Olgun H, Caner I, Sahin IO, Yolcu C (2013) Intravenous paracetamol for patent ductus arteriosus in premature infants: a lower dose is also effective. Neonatology 104:6-7
11. Van Overmeire B, Chemtob S (2005) The pharmacologic closure of the patent ductus arteriosus. Semin Fetal Neonatal Med 10:177-184
12. Yurttutan S, Oncel MY, ArayIcI S, Uras N, Altug N, Erdeve O et al (2013) A different first-choice drug in the medical management of patent ductus arteriosus: oral paracetamol. J Matern Fetal Neonatal Med 26:825-827
13. Zahka KG, Erenberg F (2011) Congenital defects. In: Martin RJ, Fanaroff AA, Walsh MC (eds) Fanaroff and Martin's neonatal-perinatal medicine: diseases of the fetus and infant, 9th edn. Elsevier Mosby, St. Louis, pp 1245-1266